-
Marchés
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Vue d'ensemble
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
SINCLAIR PHARMA
Identification
Symbole
SPH
Code ISIN
GB0033856740
Trading location
Paris
ICB
Pharmaceuticals
Site internet
www.sinclairpharma.com
Issuer website
http://www.sinclairpharma.com
Operation
Date de l'IPO
jeu 19/04/2007
IPO type
Cotation directe
Type d'IPO
Initial Public offering
Catégorie
IPO
Operation procedure
Le 19 avril 2007 : Premières négociations des actions Sinclair Pharma plc sur Eurolist. Cours de référence : le cours de clôture des actions sur le LSE la veille du 19 avril 2007, converti en € (au taux de change indicatif diffusé par le BCE à 14h15 heure de Paris).
Broker to issue
AEK - Amsterdams Effectenkantoor
BNP Paribas Securities Services